Published by Maryam Cockar on 18th November 2016
(ShareCast News) - Drug trial company Venn Life Sciences has completed the sale of its stake in Innovenn UK innovation unit to Integumen for up to £4.74m that will see it retain a majority stake as the newly created skin science company looks to float on AIM.
URL: http://www.digitallook.com/dl/news/story/25231157/...